Abstract
Introduction
Thromboembolic complications are the most frequent perioperative complications of endovascular treatment of intracranial aneurysms. Even if the effectiveness of glycoprotein IIb/IIIa inhibitors has been reported, the outcomes in published clinic data are contradictory. This study aims to assess the effectiveness and the safety of eptifibatide in thromboembolic complications during intracranial aneurysm embolization procedure.
Methods
Between 2006 and 2012, 650 patients with intracranial aneurysm were treated using endovascular coil embolization, and in 62 cases (9.5 %), an intra-arterial thrombus developed. Glycoprotein IIb/IIIa inhibitor was administrated in 45 of them who required a rescue treatment. These 45 patients were treated with an intra-arterial bolus (0.2 mg/kg) of eptifibatide. We respectively reviewed the angiographic and clinical outcomes, and the periprocedural complications of the rescue treatment.
Results
No intra- or early postoperative (48 h) bleeding was observed after treatment. A total recovery of the entire arterial tree (TICI 3) was established in 28 cases (62.2 %), a partial revascularization in 13 cases (28.8 %) (5 TICI 2A and 8 TICI 2B), and no revascularization or reperfusion (TICI 0 or TICI 1) in 4 cases (9 %). Eptifibatide was more effective on proximal obstructions and in-stent occlusions than on peripheral distal thrombus, which were completely disintegrated one time out of three.
Conclusion
Intra-operative intra-arterial use of eptifibatide does not imply an increase of hemorrhagic events. Even if eptifibatide allows for a high rate of arterial recanalization, its effectiveness seems to be less important in cases of distal occlusions.
Similar content being viewed by others
References
Wallace RC, Furlan AJ, Moliterno DJ et al (1997) Basilar artery rethrombosis: successful treatment with platelet glycoprotein IIB/IIIA receptor inhibitor. AJNR Am J Neuroradiol 18:1257–1260
Aviv RI, O'Neill R, Patel MC et al (2005) Abciximab in patients with ruptured intracranial aneurysms. AJNR Am J Neuroradiol 26:1744–1750
Gralla J, Rennie AT, Corkill RA et al (2008) Abciximab for thrombolysis during intracranial aneurysm coiling. Neuroradiology 50:1041–1047
Ries T, Siemonsen S, Grzyska U et al (2009) Abciximab is a safe rescue therapy in thromboembolic events complicating cerebral aneurysm coil embolization: single center experience in 42 cases and review of the literature. Stroke 40:1750–1757
Park JH, Kim JE, Sheen SH et al (2008) Intraarterial abciximab for treatment of thromboembolism during coil embolization of intracranial aneurysms: outcome and fatal hemorrhagic complications. J Neurosurg 108:450–457
Qureshi A, Saad M, Zaidat OO et al (2002) Intracerebral hemorrhages associated with neurointerventional procedures using a combination of antithrombotic agents including abciximab. Stroke 33:1916–1919
Walsh RD, Barrett KM, Aguilar MI et al (2011) Intracranial hemorrhage following neuroendovascular procedures with abciximab is associated with high mortality: a multicenter series. Neurocrit Care 15:85–95
Kang HS, Kwon BJ, Roh HG et al (2008) Intra-arterial tirofiban infusion for thromboembolism during endovascular treatment of intracranial aneurysms. Neurosurgery 63:230–238
Higashida RT, Furlan AJ, Roberts H (2003) Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke. Stroke 34:109–137
Matsumoto Y, Kondo R, Matsumori Y et al (2012) Antiplatelet therapy for prevention of thromboembolic complications associated with coil embolization of unruptured cerebral aneurysms. Drugs R D 12:1–7
van Rooij WJ, Sluzewski M, Beute GN et al (2006) Procedural complications of coiling of ruptured intracranial aneurysms: incidence and risk factors in a consecutive series of 681 patients. AJNR Am J Neuroradiol 27:1498–1501
Murayama Y, Nien YL, Duckwiler G et al (2003) Detachable coil embolization of cerebral aneurysms: 11 years' experience. J Neurosurg 98:959–966
Pelz DM, Lownie SP, Fox AJ (1998) Thromboembolic events associated with the treatment of cerebral aneurysms with Guglielmi detachable coils. AJNR Am J Neuroradiol 19:1541–1547
Henkes H, Fischer S, Weber W et al (2004) Endovascular coil occlusion of 1811 intracranial aneurysms: early angiographic and clinical results. Neurosurgery 54:268–285
Grunwald IQ, Papanagiotou P, Politi M et al (2006) Endovascular treatment of unruptured intracranial aneurysms: occurrence of thromboembolic events. Neurosurgery 58:612–618
Oxley TJ, Dowling RJ, Mitchell PJ et al (2011) Antiplatelet resistance and thromboembolic complications in neurointerventional procedures. Front Neurol 83:1–9
Workman MJ, Cloft HJ, Tong FC et al (2002) Thrombus formation at the neck of cerebral aneurysms during treatment with Guglielmi detachable coils. AJNR Am J Neuroradiol 23:1568–1576
Soeda A, Sakai N, Sakai H et al (2003) Thromboembolic events associated with Guglielmi detachable coil embolization of asymptomatic cerebral aneurysms: evaluation of 66 consecutive cases with use of diffusion-weighted MR imaging. AJNR Am J Neuroradiol 24:127–132
Dion JE, Gates PC, Fox AJ et al (1987) Clinical events following neuroangiography: a prospective study. Stroke 18:997–1004
Earnest F IV, Forbes G, Sandok BA et al (1984) Complications of cerebral angiography: prospective assessment of risk. AJR Am J Roentgenol 142:247–253
Sedat J, Dib M, Lonjon M et al (2002) Endovascular treatment of ruptured intracranial aneurysms in patients aged 65 years and older: follow-up of 52 patients after one year. Stroke 33:2620–2625
Pierot L, Cognard C, Anxionnat R et al (2010) Ruptured intracranial aneurysms: factors affecting the rate and outcome of endovascular treatment complications in a series of 782 patients (CLARITY study). Radiology 256:916–923
Vermeulen M, van Vliet HH, Lindsay KW et al (1985) Source of fibrin/fibrinogen degradation products in the CSF after subarachnoid hemorrhage. J Neurosurg 63:573–577
Kasuya H, Shimizu T, Okada T et al (1988) Activation of the coagulation system in the subarachnoid space after subarachnoid hemorrhage: serial measurement of fibrinopeptide A and bradykinin of cerebrospinal fluid and plasma in patients with subarachnoid hemorrhage. Acta Neurochir (Wien) 91:120–125
Ikeda K, Asakura H, Futami K et al (1997) Coagulative and fibrinolytic activation in cerebrospinal fluid and plasma after subarachnoid hemorrhage. Neurosurgery 41:344–350
Vinuela F, Duckwiler G, Mawad M (1997) Guglielmi detachable coil embolization of acute intracranial aneurysm: perioperative anatomical and clinical outcome in 403 patients. J Neurosurg 86:475–482
Katsaridis V, Papagiannaki C, Violaris C (2006) Guglielmi detachable coil versus matrix coils: a comparison of the immediate posttreatment results of the embolisation of 364 aneurysms in 307 patients: a single-center, single-surgeon experience. AJNR Am J Neuroradiol 27:1841–1848
Fiorella D, Albuquerque FC, Han P et al (2004) Strategies for the management of intraprocedural thromboembolic complications with abciximab (ReoPro). Neurosurgery 54:1089–1098
Park HK, Horowitz M, Jungreis C et al (2005) Periprocedural morbidity and mortality associated with endovascular treatment of intracranial aneurysms. AJNR Am J Neuroradiol 26:506–514
Oishi H, Yamamoto M, Shimizu T et al (2012) Endovascular therapy of 500 small asymptomatic unruptured intracranial aneurysms. AJNR Am J Neuroradiol 33:958–964
Orrù E, Roccatagliata L, Cester G et al (2013) Complications of endovascular treatment of cerebral aneurysms. Eur J Radiol 82:1653–1658
Cronquist M, Pierrot L, Boulin A et al (1998) Local intraarterial fibrinolysis of thromboemboli occurring during endovascular treatment of intracranial aneurysm: a comparison of anatomic results and clinical outcome. AJNR AmJ Neuroradiol 19:157–165
Brinjikji W, McDonald JS, Kallmes DF et al (2013) Rescue treatment of thromboembolic complications during endovascular treatment of cerebral aneurysms. Stroke 44:1343–1347
Coller BS (1997) GPIIb/IIIa antagonists: pathophysiologic and therapeutic insights from studies of c7E3 Fab. Thromb Haemost 78:730–735
Bendok BR, Padalino DJ, Levy EI et al (2004) Intravenous abciximab for parent vessel thrombus during basilar apex aneurysm coil embolization: case report and literature review. Surg Neurol 62:304–311
Alexander MJ, Duckwiler GR, Gobin YP et al (2002) Management of intraprocedural arterial thrombus in cerebral aneurysm embolization with abciximab: technical case report. Neurosurgery 50:899–902
Aggour M, Pierot L, Kadziolka K et al (2010) Abciximab treatment modalities for thromboembolic events related to aneurysm coiling. Neurosurgery 67:503–508
Song JK, Niimi Y, Fernandez PM et al (2004) Thrombus formation during intracranial aneurysm coil placement: treatment with intra-arterial abciximab. AJNR Am J Neuroradiol 25:1147–1153
Velat GJ, Burry MV, Eskioglu E et al (2006) The use of abciximab in the treatment of acute cerebral thromboembolic events during neuroendovascular procedures. Surg Neurol 65:352–359
Jones RG, Davagnanam I, Colley S et al (2008) Abciximab for treatment of thromboembolic complications during endovascular coiling of intracranial aneurysms. AJNR Am J Neuroradiol 29:1925–1929
Mounayer C, Piotin M, Baldi S et al (2003) Intraarterial administration of abciximab for thromboembolic events occurring during aneurysm coil placement. AJNR Am J Neuroradiol 24:2039–2043
Duncan IC, Fourie PA (2002) Catheter-directed intra-arterial abciximab administration for acute thrombotic occlusions during neurointerventional procedures. Interv Neuroradiol 8:159–168
Linfante I, Etezadi V, Andreone V et al (2010) Intra-arterial abciximab for the treatment of thrombus formation during coil embolization of intracranial aneurysms. J Neurointerv Surg 2:135–138
Ng PP, Phatouros CC, Khangure MS (2001) Use of glycoprotein IIb-IIIa inhibitor for a thromboembolic complication during Guglielmi detachable coil treatment of an acutely ruptured aneurysm. AJNR Am J Neuroradiol 22:1761–1763
Cloft HJ, Samuels OB, Tong FC et al (2001) Use of abciximab for mediation of thromboembolic complications of endovascular therapy. AJNR Am J Neuroradiol 22:1764–1767
Katsaridis V, Papagiannaki C, Skoulios N et al (2008) Local intra-arterial eptifibatide for intraoperative vessel thrombosis during aneurysm coiling. AJNR Am J Neuroradiol 29:1414–1417
Li YF, Spencer FA, Becker RC (2002) Comparative efficacy of fibrinogen and platelet supplementation on the in vitro reversibility of competitive glycoprotein IIb/IIIa receptor-directed platelet inhibition. Am Heart J 143:725–732
Dumont TM, Kan P, Snyder KV et al (2012) Adjunctive use of eptifibatide for complication management during elective neuroendovascular procedures. J Neurointerv Surg 12:36–43
Yi HJ, Gupta R, Jovin TG et al (2006) Initial experience with the use of intravenous eptifibatide bolus during endovascular treatment of intracranial aneurysms. AJNR Am J Neuroradiol 27:1856–1860
Bruening R, Mueller-Schunk S, Morhard D et al (2006) Intraprocedural thrombus formation during coil placement in ruptured intracranial aneurysms: treatment with systemic application of the glycoprotein IIb/IIIa antagonist tirofiban. AJNR Am J Neuroradiol 27:1326–1331
Jeon JS, Sheen SH, Hwang G et al (2012) Intraarterial tirofiban thrombolysis for thromboembolisms during coil embolization for ruptured intracranial aneurysms. J Cerebrovasc Endovasc Neurosurg 14:5–10
Cho YD, Lee JY, Seo JH et al (2012) Intra-arterial tirofiban infusion for thromboembolic complication during coil embolization of ruptured intracranial aneurysms. Eur J Radiol 81:2833–2838
Chalouhi N, Jabbour P, Kung D et al (2012) Safety and efficacy of tirofiban in stent-assisted coil embolization of intracranial aneurysms. Neurosurgery 71:710–714
Ciccone A, Valvassori L, Nichelatti M, The SYNTHESIS Expansion Investigators et al (2013) Endovascular treatment for acute ischemic stroke. N Engl J Med 10:904–913
Adams HP Jr, Effron MB, Torner J et al (2008) Emergency administration of abciximab for treatment of patients with acute ischemic stroke: results of an international phase III trial: abciximab in emergency treatment of stroke trial (AbESTT-II). Stroke 39:87–99
The EPIC Investigators (1994) Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. N Engl J Med 330:956–961
The CAPTURE Investigators (1997) Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE study. Lancet 349:1429–1435
Qureshi AI, Suri MF, Khan J et al (2000) Abciximab as an adjunct to high-risk carotid or vertebrobasilar angioplasty: preliminary experience. Neurosurgery 46:1316–1325
Hillegass WB, Newman AR, Raco DL (1999) Economic issues in glycoprotein IIb/IIIa receptor therapy. Am Heart J 138:24–32
Conflict of interest
We declare we have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sedat, J., Chau, Y., Mondot, L. et al. Is eptifibatide a safe and effective rescue therapy in thromboembolic events complicating cerebral aneurysm coil embolization? Single-center experience in 42 cases and review of the literature. Neuroradiology 56, 145–153 (2014). https://doi.org/10.1007/s00234-013-1301-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00234-013-1301-3